Skip to main content

Advertisement

Log in

Mitochondrial neurogastrointestinal encephalomyopathy in three siblings

Clinical, genetic and neuroradiological features

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare autosomal recessive disorder in which a nuclear mutation of the thymidine phosphorylase (TP) gene causes mitochondrial genomic dysfunction. Patients suffer from gastrointestinal dysmotility, cachexia, ptosis, external ophthalmoparesis, myopathy and polyneuropathy. Magnetic resonance imaging (MRI) shows leukoencephalopathy. We describe clinical, genetic and neuroradiological features of three brothers affected with MNGIE. Clinical examination, laboratory analyses, MRI and magnetic resonance spectroscopy (MRS) of the brain, and genetic analysis have been performed in all six members of the family with the three patients with MNGIE. Two of them are monozygous twins. They all suffered from gastrointestinal dysmotility, cachexia, ophthalmoplegia, muscular atrophies, and polyneuropathy. Urinary thymidine was elevated in the patients related to the severity of clinical disease, and urinary thymidine (normally not detectable) was also found in a heterozygous carrier. Brain MRI showed leukoencephalopathy in all patients; however, their cognitive functioning was normal. Brain MRS demonstrated reduced N-acetylaspartate and choline in severely affected areas. MRI of heterozygous carriers was normal. A new mutation (T92N) in the TP gene was identified. Urinary thymidine is for the first time reported to be detectable in a heterozygous carrier. MRS findings indicate loss of neurons, axons, and glial cells in patients with MNGIE, but not in heterozygous carriers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Okamura K, Santa T, Nagae K, et al. (1976) Congenital okuloskeletal myopathy with abnormal muscle and liver mitochondria. J Neurol Sci 27:79–91

    Article  PubMed  CAS  Google Scholar 

  2. Ionasescu V (1983) Oculogastrointestinal muscular Dystrophy. Am J Med Genet 15:103–112

    Article  PubMed  CAS  Google Scholar 

  3. Cervera R, Bruix J, Bayes A, et al. (1988) Chronic intestinal pseudoobstruction and ophthalmoplegia in a patient with mitochondrial myopathy. Gut 29:544–547

    PubMed  CAS  Google Scholar 

  4. Threlkeld AB, Miller NR, Golnik KC, et al. (1992) Ophthalmic involvement in myo-neuro-gastrointestinal encephalopathy syndrome. Am J Ophthal 114:322–328

    PubMed  CAS  Google Scholar 

  5. Simon LT, Horoupian DS, Dorfman LJ, et al. (1990) Polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudo-obstruction: POLIP syndrome. Ann Neurol 28:349–360

    Article  PubMed  CAS  Google Scholar 

  6. Faber J, Fich A, Steinberg A, et al. (1987) Familial intestinal pseudoobstruction dominated by progressive nbeurologic disease at a young age. Gastroenterology 92:786–790

    PubMed  CAS  Google Scholar 

  7. Bardosi A, Creutzfeldt W, DiMauro S, et al. (1987) Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to a partial deficiency of cytochrome-c-oxidase. Acta Neuropathol (Berlin) 74:248–258

    Article  CAS  Google Scholar 

  8. Teitelbaum JE, Berde CB, Nurko S, et al. (2002) Diagnosis and management of MNGIE syndrome in children: Case report and review of the literature. J Pediatr Gastroenterol Nutr 35:377–383

    Article  PubMed  CAS  Google Scholar 

  9. Uncini A, Servidei S, Silvestri G, et al. (1994) Ophthalmoplegia, demyelinating neuropathy, leukoencephalopathy,myopathy, and gastrointestinal dysfunction with multiple deletions of mitochondrial DNA: A mitochondrial multisystem disorder in search of a name. Muscle Nerve 17:667–674

    Article  PubMed  CAS  Google Scholar 

  10. Blake D, Lombes A, Minetti C, et al. (1990) MNGIE syndrome: Report of 2 new patients [abstract]. Neurology 40(suppl 1):294(643S)

    Google Scholar 

  11. Debouverie M, Wagner M, Ducrocq X, et al. (1997) Le MNGIE syndrome: deux cas dans une même fratrie. Rev Neurol (Paris) 153:547–553

    CAS  Google Scholar 

  12. Steiner I, Steinberg A, Argov Z, et al. (1987) Familial progressive neuronal disease and chronic idiopathic intestinal pseudo-obstruction. Neurology 37:1046–1050

    PubMed  CAS  Google Scholar 

  13. Papadimitriou A, Comi GP, Hadjigeorgiou GM, et al. (1998) Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome. Neurology 51:1086–1092

    PubMed  CAS  Google Scholar 

  14. Hirano M, Silvestri G, Blake DM, et al. (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44:721–727

    PubMed  CAS  Google Scholar 

  15. Sabatelli M, Servidei S, Ricci E, et al. (1992) Myo-neuro-gastro-intestinal disease and encephalopathy (MNGIE syndrome): a patient with multiple deletions of mitochondrial DNA [abstract]. Neurology 42(suppl 3):418

    Google Scholar 

  16. Carrozzo R, Hirano M, Fromenty B, et al. (1998) Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses. Neurology 50:99–106

    Article  PubMed  CAS  Google Scholar 

  17. Cave DR (1990) Case records of the Massachusetts General Hospital, Case 12–1990. New Engl J Med 322:829–841

    Article  Google Scholar 

  18. Mueller LA, Camilleri M, Emslie-Smith AM (1999) Mitochondrial neurogastrointestinal encephalomyopathy: Manometric and diagnostic features. Gastroenterology 116:959–963

    Article  PubMed  CAS  Google Scholar 

  19. Lowsky R, Davidson G, Wolman S, et al. (1993) Familial visceral myopathy associated with a mitochondrial myopathy. Gut 34:279–283

    PubMed  CAS  Google Scholar 

  20. Nishino I, Spinazzola A, Papadimitriou A, et al. (2000) Mitochondrial Neurograstrointestinal Encephalomyopathy: An Autosomal Recessive Disorder due to Thymidine Phosphorylase Mutations. Ann Neurol 47:792–800

    Article  PubMed  CAS  Google Scholar 

  21. Labague P, Durant R, Castelnuovo G, et al. (2002) MNGIE: Diarrhea and leukoencephalopathy. Neurology 58:1862

    Google Scholar 

  22. Gamez J, Ferreiro C, Accarino ML, et al. (2002) Phenotypic variability in a Spanish family with MNGIE. Neurology 59:455–457

    Article  PubMed  CAS  Google Scholar 

  23. Hamano H, Ohta T, Takekawa Y, et al. (1997) Mitochondrial neurogasrtointestinal encephalomyopathy presenting with protein-losing gastroenteropathy and serum copper deficiency: a case report. Rinsho Shinkeigaku 37:917–922

    PubMed  CAS  Google Scholar 

  24. Kocaefe YC, Erdem S, Özgüç M, et al. (2003) Four novel thymidine phosphorylase gene mutations in mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE) patients. Eur J Hum Genet 11:102–104

    Article  PubMed  CAS  Google Scholar 

  25. Chaury F, Fleury M, Tranchant C (2002) Cas clinique. Troubles digestifs révélateurs d’une cytopathie mitochondriale: le syndrome MNGIE. Rev Neurol (Paris) 158:111–113

    CAS  Google Scholar 

  26. Rafai MA, Laforet P, El Moutawakil B, et al. (2004) Mitochondriopathie type MNGIE «mitochondrial neuro-gastro-intestinal encephalopathy» [abstract]. Rev Neurol (Paris) 160(Spl.3):3S117

    Google Scholar 

  27. Martin MA, Blazquez A, Marti R, et al. (2004) Lack of gastrointestinal symptoms in a 60-year-old patient with MNGIE. Neurology 63:1536–7

    PubMed  CAS  Google Scholar 

  28. Szigeti K, Wong LJ, Perng CL, et al. (2004) MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation. J Med Genet 41:125–9

    Article  PubMed  CAS  Google Scholar 

  29. Peker S, Pamir MN (2005) Trigeminal nevralgia in a patient with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Clin Neurosci 12:172–174

    Article  PubMed  Google Scholar 

  30. Gamez J, Lara MC, Mearin F, et al. (2005) A novel thymidine phosphorylase mutation in a Spanish MNGIE patient. J Neurol Sci 228:35–39

    Article  PubMed  CAS  Google Scholar 

  31. Slama A, Lacroix C, Plante-Bordeneuve V, et al. (2005) Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome. Mol Genet Metab 84:326–31

    Article  PubMed  CAS  Google Scholar 

  32. Martí R, Verschuuren JJ, Buchman A, et al. (2005) Late-onset MNGIE due to partial loss of thymidine phosphorylase activity. Ann Neurol 58:649–652

    Article  PubMed  CAS  Google Scholar 

  33. Blazquez A, Martín MA, Lara MC, et al. (2005) Increased muscle nucleoside levels associated with a novel frameshift mutation in the thymidine phosphorylase gene in a Spanish patient with MNGIE. Neuromuscul Disord 15:775–778

    Article  PubMed  CAS  Google Scholar 

  34. Hirano M, Garcia-de-Yebenes J, Jones AC, et al. (1998) Mitochondrial Neurogastrointestinal Encephalomyopathy Syndrome Maps to Chromosome 22q13.32-qter. Am J Hum Genet 63:526–533

    Article  PubMed  CAS  Google Scholar 

  35. Nishino I, Spinazzola A, Hirano M (1999) Thymidine Phosphorylase Gene Mutations in MNGIE, a Human Mitochondrial Disorder. Science 283:689–692

    Article  PubMed  CAS  Google Scholar 

  36. Hirano M, Martí R, Casali C, et al. (2006) Allogenic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67:1458–1460

    Article  PubMed  CAS  Google Scholar 

  37. Bedlack RS, Vu T, Hammans S, et al. (2004) MNGIE neuropathy: Five cases mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 29:364–368

    Article  PubMed  Google Scholar 

  38. Slotboom J, Boesch C, Kreis R (1998) Versatile Frequency Domain Fitting using Time Domain Models and Prior Knowledge. Magn Reson Med 39:899–911

    PubMed  CAS  Google Scholar 

  39. Simmonds HA, Duley JA, Davies PM (1990) Analysis of purines and pyrimidines in blood, urine, and other physiological fluids. Chapter 25 In: Hommes FA, (Eds.), Techniques in diagnostic human biochemical genetics. A laboratory manual. John Wiley & Sons, 397–424

    Google Scholar 

  40. Rowland LP (1992) Progressive external ophthalmoplegia. In: Vinkens PJ, Bruyn GW, Klawans HL, (eds.) Handbook of clinical neurology. Elsevier, Amsterdam 287–329

    Google Scholar 

  41. Spinazzola A, Martí R, Nishino I, et al. (2002) Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 277:4128–4133

    Article  PubMed  CAS  Google Scholar 

  42. Martí R, Nishigaki Y, Hirano M (2003) Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochem Biophys Res Comm 303:14–18

    Article  PubMed  CAS  Google Scholar 

  43. Ferraro P, Pontarin G, Crocco L, et al. (2005) Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Biol Chem 280:24472–80

    Article  PubMed  CAS  Google Scholar 

  44. Hirano M, Nishigaki Y, Martí R (2004) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): A disease of two genomes. Neurologist 10:8–17

    Article  PubMed  Google Scholar 

  45. Hirano M, Lagier-Tourenne C, Valentino ML, et al. (2005) Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene 354:152–6

    Article  PubMed  CAS  Google Scholar 

  46. Martí R, Spinazzola A, Tadesse S, et al. (2004) Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. Clin Chem 50:120–124

    Article  PubMed  CAS  Google Scholar 

  47. Fairbanks LD, Marinaki AM, Carrey EA, et al. (2002) Deoxyuridine accumulation in urine in thymidine phosphorylase deficiency (MNGIE). J Inherit Metab Dis 25:603–604

    Article  PubMed  CAS  Google Scholar 

  48. Pfefferbaum A, Adalsteinsson E, Spielman D, et al. (1999) In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain grey and white matter: Effects of normal aging. Magn Reson Med 41:276–284

    Article  PubMed  CAS  Google Scholar 

  49. Lundbom N, Barnett A, Bonavita S, et al. (1999) MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain. Magn Reson Med 41:841–845

    Article  PubMed  CAS  Google Scholar 

  50. Simmons ML, Frondoza CG, Coyle JT (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45:37–45

    Article  PubMed  CAS  Google Scholar 

  51. Miller BL, Chang L, Booth R, et al. (1996) In Vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 58:1929–1935

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr. M. Hirano, Columbia University, New York, for the assessment of the leucocyte TP activity in the index patient. We also thank Dr. P. Voore, Toronto, Canada, for critical reading of this manuscript, Dr. JM Nuoffer, University Hospital Berne, Switzerland, for clinical advice, and J. Slotboom, PhD, for the development and implementation of the MRS-quantification technique and his assistance in acquiring the MR spectra for this study. This work was supported by grant No 81BE-67704 of the Swiss National Science Foundation and the Swiss Parkinson’s Disease Association.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H.P. Mattle.

Additional information

Received in revised form: 26 March 2006

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schüpbach, W., Vadday, K.M., Schaller, A. et al. Mitochondrial neurogastrointestinal encephalomyopathy in three siblings. J Neurol 254, 146–153 (2007). https://doi.org/10.1007/s00415-006-0255-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0255-3

Keywords

Navigation